These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 30850581)
1. HLA class II antibodies induce necrotic cell death in human endothelial cells via a lysosomal membrane permeabilization-mediated pathway. Aljabri A; Vijayan V; Stankov M; Nikolin C; Figueiredo C; Blasczyk R; Becker JU; Linkermann A; Immenschuh S Cell Death Dis; 2019 Mar; 10(3):235. PubMed ID: 30850581 [TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial cells evade apoptosis triggered by human leukocyte antigen-DR ligation mediated by allospecific antibodies. Le Bas-Bernardet S; Coupel S; Chauveau A; Soulillou JP; Charreau B Transplantation; 2004 Dec; 78(12):1729-39. PubMed ID: 15614145 [TBL] [Abstract][Full Text] [Related]
3. Negative regulation of HLA-DR expression on endothelial cells by anti-blood group A/B antibody ligation and mTOR inhibition. Iwasaki K; Miwa Y; Uchida K; Kodera Y; Kobayashi T Transpl Immunol; 2017 Feb; 40():22-30. PubMed ID: 28017877 [TBL] [Abstract][Full Text] [Related]
5. Interferon-γ-induced HLA Class II expression on endothelial cells is decreased by inhibition of mTOR and HMG-CoA reductase. Maenaka A; Kenta I; Ota A; Miwa Y; Ohashi W; Horimi K; Matsuoka Y; Ohnishi M; Uchida K; Kobayashi T FEBS Open Bio; 2020 May; 10(5):927-936. PubMed ID: 32237049 [TBL] [Abstract][Full Text] [Related]
6. The suppressive effect on CD4 T cell alloresponse against endothelial HLA-DR via PD-L1 induced by anti-A/B ligation. Iwasaki K; Hamana H; Kishi H; Yamamoto T; Hiramitsu T; Okad M; Tomosugi T; Takeda A; Narumi S; Watarai Y; Miwa Y; Okumura M; Matsuoka Y; Horimi K; Muraguchi A; Kobayash T Clin Exp Immunol; 2020 Nov; 202(2):249-261. PubMed ID: 32578199 [TBL] [Abstract][Full Text] [Related]
7. Endothelial permeability is increased by the supernatant of peripheral blood mononuclear cells stimulated with HLA Class II antibody. Wakamoto S; Fujihara M; Sakagawa H; Takahashi D; Niwa K; Morioka M; Sato S; Kato T; Azuma H; Ikeda H Transfusion; 2008 Oct; 48(10):2060-8. PubMed ID: 18564388 [TBL] [Abstract][Full Text] [Related]
8. Sox7 is involved in antibody-dependent endothelial cell activation and renal allograft injury via the Jagged1-Notch1 pathway. Qin Y; Sun B; Zhang F; Wang Y; Shen B; Liu Y; Guo Y; Fan Y; Qiu J Exp Cell Res; 2019 Feb; 375(2):20-27. PubMed ID: 30639059 [TBL] [Abstract][Full Text] [Related]
9. Upregulation of Endothelial HLA Class II is a Marker of Antibody-Mediated Rejection in Heart Allograft Biopsies. Cai Q; Moore SA; Hendricks AR; Torrealba JR Transplant Proc; 2020 May; 52(4):1192-1197. PubMed ID: 32197864 [TBL] [Abstract][Full Text] [Related]
10. Characterization of the endothelial cell cytoskeleton following HLA class I ligation. Ziegler ME; Souda P; Jin YP; Whitelegge JP; Reed EF PLoS One; 2012; 7(1):e29472. PubMed ID: 22247778 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of lymphocyte adhesion to human vascular endothelial cells in culture. T lymphocyte adhesion to endothelial cells through endothelial HLA-DR antigens induced by gamma interferon. Masuyama J; Minato N; Kano S J Clin Invest; 1986 May; 77(5):1596-605. PubMed ID: 3084562 [TBL] [Abstract][Full Text] [Related]
12. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Narayanan K; Jendrisak MD; Phelan DL; Mohanakumar T Transpl Immunol; 2006 Jan; 15(3):187-97. PubMed ID: 16431285 [TBL] [Abstract][Full Text] [Related]
13. HLA Class II-Triggered Signaling Cascades Cause Endothelial Cell Proliferation and Migration: Relevance to Antibody-Mediated Transplant Rejection. Jin YP; Valenzuela NM; Zhang X; Rozengurt E; Reed EF J Immunol; 2018 Apr; 200(7):2372-2390. PubMed ID: 29475988 [TBL] [Abstract][Full Text] [Related]
14. Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells. Jin YP; Fishbein MC; Said JW; Jindra PT; Rajalingam R; Rozengurt E; Reed EF Hum Immunol; 2004 Apr; 65(4):291-302. PubMed ID: 15120184 [TBL] [Abstract][Full Text] [Related]
15. Class II HLA Eplet Mismatch Is a Risk Factor for De Novo Donor-Specific Antibody Development and Antibody-mediated Rejection in Kidney Transplantation Recipients. Kishikawa H; Kinoshita T; Hashimoto M; Fukae S; Taniguchi A; Yamanaka K; Nakagawa M; Nishimura K Transplant Proc; 2018 Oct; 50(8):2388-2391. PubMed ID: 30316363 [TBL] [Abstract][Full Text] [Related]
16. Effect of interferon-gamma and tumor necrosis factor on the expression of class I and class II major histocompatibility molecules by cultured human umbilical vein endothelial cells. Wedgwood JF; Hatam L; Bonagura VR Cell Immunol; 1988 Jan; 111(1):1-9. PubMed ID: 3123068 [TBL] [Abstract][Full Text] [Related]
17. HLA Class II Antibody Activation of Endothelial Cells Promotes Th17 and Disrupts Regulatory T Lymphocyte Expansion. Lion J; Taflin C; Cross AR; Robledo-Sarmiento M; Mariotto E; Savenay A; Carmagnat M; Suberbielle C; Charron D; Haziot A; Glotz D; Mooney N Am J Transplant; 2016 May; 16(5):1408-20. PubMed ID: 26614587 [TBL] [Abstract][Full Text] [Related]
18. Contact-dependent endothelial class II HLA gene activation induced by NK cells is mediated by IFN-gamma-dependent and -independent mechanisms. Watson CA; Petzelbauer P; Zhou J; Pardi R; Bender JR J Immunol; 1995 Apr; 154(7):3222-33. PubMed ID: 7897208 [TBL] [Abstract][Full Text] [Related]
19. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340 [TBL] [Abstract][Full Text] [Related]
20. HLA class I-mediated stress fiber formation requires ERK1/2 activation in the absence of an increase in intracellular Ca2+ in human aortic endothelial cells. Ziegler ME; Jin YP; Young SH; Rozengurt E; Reed EF Am J Physiol Cell Physiol; 2012 Oct; 303(8):C872-82. PubMed ID: 22914643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]